ArticleMedicine2025
Immunological mediators in the causal relationship between latent autoimmune diabetes in adults and breast cancer: A Mendelian randomization analysis.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
To investigate the link between Latent Autoimmune Diabetes in Adults (LADA) and breast cancer (BC) subtypes using Mendelian randomization (MR) and identify potential immunological mediators. We used MR with genetic variants as instruments, leveraging genome-wide association studies data from Europeans to assess the relationship between LADA and BC subtypes. The study evaluated the mediating role of immune cells and employed methods like inverse variance weighted, MR Egger, and MR-PRESSO to ensure robust results. LADA showed a negative association with overall BC, human epidermal growth factor receptor 2-positive BC, and estrogen receptor-positive BC. The FinnGen Biobank replication and meta-analysis confirmed these inverse relationships. CD11c on CD62L+ myeloid dendritic cells mediated the relationship between LADA and BC risk. Our study indicated a negative association between LADA and BC development, especially for human epidermal growth factor receptor 2-positive and estrogen receptor-positive subtypes, with CD11c on CD62L+ myeloid dendritic cells as a key mediator. These findings suggest potential mechanisms for LADA's influence on BC risk and highlight opportunities for targeted prevention and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.